Radient Pharmaceuticals Corporation fka RXPC

[Gold Seeker]

As I stated before, I called the number listed on the website. An office manager named Jennifer answered. I asked her some simple questions like how many employees, and she refuse to answer. She wanted to know why I was calling and I just stated that another investor had read the press release and asked me to check out the company. She took my number and said Gartner would call me back.

No call back of course. Gartner wants ZERO hard questions and just wants to speak with "fish".

Here are some things to consider. When the LC Sentinel test was on the provista pipeline, it was just a lung cancer test. It absolutely did not have any restrictions about being used for smokers and former smokers.

These are the numbers given in a press release about the partnership with Radient at that time. This was strictly a DR70 test and ALL the reagents would be provided by Radient.

"The study included men and women between 20-76 years of age. The data generated in this final study proved consistent with previous findings and produced positive clinical performance marks of 87% sensitivity; 95% specificity; and an ROC Accuracy of 0.97."

http://finance.yahoo.com/news/Radient-Pharmaceuticals-and-iw-1271623575.html

Now look at the "fundable" data.

"The Lung Cancer Test can detect the presence of lung cancer in high-risk populations with a sensitivity of 87% and a specificity of 95%. The overall accuracy of the test is 97%, defined by the area under the receiver-operating characteristic (ROC) curve."

http://www.fundable.com/the-lung-cancer-test

It is the identical numbers stated by provista when it had zero restrictions on who was given the test.

To have the same numbers is IMPOSSIBLE